Clene Inc
CLNN
NASDAQ
Biotechnology
$4.14
USD
-0.05 (-1.19%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $53.54M
Volume 58.7K
Revenue
$134,000
TTM
-61.7%
YoY
Gross Margin
83%
TTM
+5.0%
YoY
Net Income
$-33.51M
TTM
-15.3%
YoY
Operating Cash Flow
$-18.06M
TTM
+6.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
YoY Growth | +11.0% | -70.3% | -82.8% | -15.4% | -81.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
Selling, General & Administrative | 2.7 | 2.4 | 2.2 | 2.0 | 1.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 4.1 | 5.9 | 5.7 | 7.5 | 2.1 |
Operating Income | -4.1 | -5.9 | -5.6 | -7.5 | -2.1 |
EBITDA | -3.7 | -5.5 | -5.3 | -7.1 | -1.7 |
Other Income / Expense | 3.9 | -0.9 | -2.5 | -1.0 | -5.3 |
Total Other Income / Expense | 3.3 | -1.6 | -3.1 | -1.7 | -6.0 |
Income Before Income Taxes | -0.8 | -7.4 | -8.8 | -9.2 | -8.1 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -0.8 | -7.4 | -8.8 | -9.2 | -8.1 |
Consolidated Net Income / Loss | -0.8 | -7.4 | -8.8 | -9.2 | -8.1 |
Net Income Attributable to Common Shareholders | -0.8 | -7.4 | -8.8 | -9.2 | -8.1 |
Basic EPS | -$0.09 | -$0.78 | -$0.85 | -$0.85 | -$0.69 |
Diluted EPS | -$0.09 | -$0.78 | -$0.85 | -$0.85 | -$0.69 |
Basic Shares Outstanding | 8.8M | 9.5M | 10.3M | 10.8M | 11.6M |
Diluted Shares Outstanding | 8.8M | 9.5M | 10.3M | 10.8M | 11.6M |